Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Macrobio is an Ecuador-based shrimp hatchery and aquaculture company rather than a human life sciences, biotech, pharma, or healthcare company. The business focuses on shrimp breeding, hatchery operations, and supplying Pacific whiteleg shrimp post-larvae to Ecuadorian farmers using advanced genetics, breeding technologies, and nutritional solutions. In 2019, Macrobio was acquired as part of a partnership led by Hendrix Genetics, together with Nutreco and Ecuacultivos, to upgrade the existing hatchery into a state-of-the-art shrimp breeding operation. Macrobio appears to remain an active operating entity within the Hendrix Genetics aquaculture portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Macrobio.